<DOC>
	<DOCNO>NCT00534651</DOCNO>
	<brief_summary>The purpose study determine effect orally give paracetamol vascular function 24-hour blood pressure patient coronary artery disease</brief_summary>
	<brief_title>Paracetamol Endothelial Function Patients With Stable Coronary Artery Disease</brief_title>
	<detailed_description>Patients chronic pain disease ( e.g . osteoarthritis ) dependent effective medication . NSAIDs effective lowering pain patient . Recently arouse major concern regard cardiovascular side effect safety , especially selective cyclooxygenase-2 inhibitor ( coxibs ) also `` regular '' NSAIDs . At moment , big confusion , whether drug still use , especially patient know coronary artery disease . Physicians try switch high dose paracetamol , despite weak efficacy pain relieve , drug consider generally harmful . As information cardiovascular effect drug , plan perform study investigate impact paracetamol endothelial function , important cardiovascular surrogate marker , inflammatory marker oxidative stress patient coronary artery disease top standard medication , include aspirin</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Age : 30 80 year History coronary artery disease ( documented coronary angiogram , nuclear imaging , positive stress test ) Stable cardiovascular medication least 1 month Written obtain informed consent myocardial infarction , unstable angina , stroke within 3 month prior study entry coronary intervention/revascularisation procedure within 3 month prior study entry Left ventricular ejection fraction &lt; 50 % Other analgesic ( Platelet inhibition therapy Aspirin 100mg/d continue ) Long act nitrate Smoking Chronic heart failure ( &gt; NYHA II ) Ventricular tachyarrhythmias Renal failure ( serum creatinine &gt; 200umol ) Liver disease ( ALT AST &gt; 100 IU ) , especially acute hepatitis Hyperbilirubinemia Alcohol abuse Oral Anticoagulation Concomitant therapy Phenobarbital , Phenytoin , Carbamazepin , Isonicotinic Acid , Chloramphenicol Chlorzoxazone , Zidovudine , Salicylamide Insulindependent diabetes mellitus Drug abuse Anemia ( Hb &lt; 10 g/dl ) Known allergy Paracetamol Pregnancy Malignancy ( unless heal remission &gt; 5 year ) Symptomatic hypotension , hypertension &gt; 160/100 mmHg Disease systemic inflammation ( e.g . rheumatoid arthritis , M. Crohn ) Participation another study within last month</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>